Monetary Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Hold |
555
| – | – | 0.06% | 188 |
|
|
2025
Q1 | $269K | Sell |
555
-50
| -8% | -$24.2K | 0.07% | 176 |
|
|
2024
Q4 | $244K | Sell |
605
-565
| -48% | -$228K | 0.06% | 186 |
|
|
2024
Q3 | $544K | Sell |
1,170
-50
| -4% | -$23.3K | 0.14% | 138 |
|
|
2024
Q2 | $572K | Buy |
1,220
+100
| +9% | +$46.9K | 0.15% | 129 |
|
|
2024
Q1 | $468K | Buy |
+1,120
| New | +$468K | 0.13% | 139 |
|
|
2021
Q3 | – | Sell |
-300
| Closed | -$60K | – | 352 |
|
|
2021
Q2 | $60K | Hold |
300
| – | – | 0.02% | 240 |
|
|
2021
Q1 | $64K | Sell |
300
-150
| -33% | -$32K | 0.02% | 227 |
|
|
2020
Q4 | $106K | Hold |
450
| – | – | 0.03% | 198 |
|
|
2020
Q3 | $122K | Hold |
450
| – | – | 0.04% | 182 |
|
|
2020
Q2 | $131K | Hold |
450
| – | – | 0.05% | 170 |
|
|
2020
Q1 | $107K | Hold |
450
| – | – | 0.05% | 163 |
|
|
2019
Q4 | $99K | Hold |
450
| – | – | 0.04% | 198 |
|
|
2019
Q3 | $76K | Buy |
+450
| New | +$76K | 0.03% | 213 |
|
|
2015
Q3 | – | Sell |
-250
| Closed | -$31K | – | 344 |
|
|
2015
Q2 | $31K | Sell |
250
-600
| -71% | -$74.4K | 0.01% | 280 |
|
|
2015
Q1 | $100K | Buy |
+850
| New | +$100K | 0.04% | 203 |
|